Patent: 9,616,180
✉ Email this page to a colleague
Summary for Patent: 9,616,180
| Title: | Automatic injection device with a top release mechanism |
| Abstract: | The present invention relates to a handheld mechanical injection device by which set doses of a liquid medicament can be injected from a medical reservoir. The medicament is expelled through an injection needle by release of a power reservoir in the device, the power reservoir being fully or partially released by actuation of a user operable release member being positioned at or near an upper end of the injection device, the upper end being that end of the injection device which is opposite the injection needle. |
| Inventor(s): | Markussen Tom Hede |
| Assignee: | Novo Nordisk A/S |
| Application Number: | US14797350 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,616,180 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 9,616,180
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc. | LEVEMIR | insulin detemir | Injection | 021536 | June 16, 2005 | ⤷ Start Trial | 2035-07-13 |
| Novo Nordisk Inc. | LEVEMIR | insulin detemir | Injection | 021536 | October 31, 2013 | ⤷ Start Trial | 2035-07-13 |
| Novo Nordisk Inc. | NOVOLOG MIX 50/50 | insulin aspart protamine and insulin aspart | Injectable Suspension | 021810 | August 26, 2008 | ⤷ Start Trial | 2035-07-13 |
| Seqirus Inc. | FLUAD | influenza vaccine, adjuvanted | Injection | 125510 | November 24, 2015 | ⤷ Start Trial | 2035-07-13 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,616,180
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2006076921 | ⤷ Start Trial |
| United States of America | 9108002 | ⤷ Start Trial |
| United States of America | 8096978 | ⤷ Start Trial |
| United States of America | 2024366880 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
